| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/19/2007 | WO2006128180A3 Methods for the treatment of disease |
| 04/19/2007 | WO2006121807A3 Assay for cytochrome p450 isoform 2c8 |
| 04/19/2007 | WO2006117381A3 Transgenic expression cartridges for expressing nucleic acids in the flower tissue of plants |
| 04/19/2007 | WO2006116541A3 Tat-002 and methods of assessing and treating cancer |
| 04/19/2007 | WO2006108659A3 Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds |
| 04/19/2007 | WO2006088940A3 Neoplasia screening compositions and methods of use |
| 04/19/2007 | WO2006085963A3 Controls for determining reaction performance in polynucleotide sequence detection assays |
| 04/19/2007 | WO2006081494A3 Induction of tumor cell senescence by retinoid receptor agonists and antagonists |
| 04/19/2007 | WO2006075039A3 Method for the in vitro diagnosis of familial hypercholesterolemia, comprising the detection of gene rearrangements |
| 04/19/2007 | WO2006071805A3 Perinucleolar compartment markers for cancers |
| 04/19/2007 | WO2006065897A3 Device for the detection of prions |
| 04/19/2007 | WO2006060723A3 Methods for producing block copolymer/amphiphilic particles |
| 04/19/2007 | WO2006052731A3 Molecular indicators of breast cancer prognosis and prediction of treatment response |
| 04/19/2007 | WO2006047536A3 Methods and kits for detecting mutations |
| 04/19/2007 | WO2006042022A3 Array-based methods for producing ribonucleic acids |
| 04/19/2007 | WO2006029052A8 Methods for assessing atherosclerosis |
| 04/19/2007 | WO2006027703A3 Analyte detecting member with a hydrogel |
| 04/19/2007 | WO2005116266A3 Methods of amplifying infectious proteins |
| 04/19/2007 | WO2005111234A3 Methods of using zc1 and zc3 kinase substrate phosphorylation as biomarkers |
| 04/19/2007 | WO2005079367A3 Schizochytrium fatty acid synthase (fas) and products and methods related thereto |
| 04/19/2007 | WO2005079277A3 High throughput screening methods for lubricating oil compositions |
| 04/19/2007 | WO2005056802A3 Materials and methods relating to cell cycle control |
| 04/19/2007 | WO2004112694A3 Immunogenic reagents from west nile virus |
| 04/19/2007 | WO2004098537A3 Activation agents on the surface of encapsulation vesicles |
| 04/19/2007 | WO2004088279A3 Allosteric probes and methods |
| 04/19/2007 | WO2004080392A3 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth |
| 04/19/2007 | WO2004069849A8 Bead emulsion nucleic acid amplification |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070089202 Use of untranslated region of osmotin gene to enhance transgene expression in plants |
| 04/19/2007 | US20070089182 Regeneration |
| 04/19/2007 | US20070089180 Transcription factors of cereals |
| 04/19/2007 | US20070089179 provides cell lines and transgenic animals for use in identifying modulators of SREBP2gc transcription factors; provides therapeutic agents that modulate SREBP2gc signaling for use as fertility modulators; drug screening |
| 04/19/2007 | US20070088513 Producing system and its control device, control method, control system and control program |
| 04/19/2007 | US20070088510 Method and system for faster and more sensitive homology searching |
| 04/19/2007 | US20070088155 siRNA targeting tumor necrosis factor superfamily member 1A |
| 04/19/2007 | US20070088154 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 04/19/2007 | US20070088153 siRNA targeting BCL2L1 |
| 04/19/2007 | US20070088152 siRNA targeting KRAS |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/19/2007 | US20070087988 Hematopoietic progenitor kinase 1 for modulation of an immune response |
| 04/19/2007 | US20070087985 MRCK-related compositions and methods |
| 04/19/2007 | US20070087983 Novel ubp8rp polypeptides and their use in the treatment of psoriasis |
| 04/19/2007 | US20070087982 Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences |
| 04/19/2007 | US20070087435 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 04/19/2007 | US20070087433 Adeno-associated viral vector for use as heterologous gene transfer agent |
| 04/19/2007 | US20070087427 Crystal structure of a deacetylase and inhibitors thereof |
| 04/19/2007 | US20070087416 Hyaluronan synthase gene and uses thereof |
| 04/19/2007 | US20070087412 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
| 04/19/2007 | US20070087409 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/19/2007 | US20070087401 Analysis of metabolic activity in cells using extracellular flux rate measurements |
| 04/19/2007 | US20070087400 Covalent tethering of functional groups to proteins and substrates therefor |
| 04/19/2007 | US20070087399 Lactate biosensing strip and method for manufacture thereof |
| 04/19/2007 | US20070087398 Inactivated Enzyme Variants And Associated Process And Reagent System |
| 04/19/2007 | US20070087397 Sampling the test current at a predetermined sampling rate to acquire a number of analog/digital conversions; filtering out the extreme numbers; calculating an average of the accepted A/D conversions ;and converting the average into a glucose concentration. |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | US20070087385 Spherical and magnetical silicagel carriers having an increase surface for purifying nucleic acids |
| 04/19/2007 | US20070087379 Nucleotide sequences coding protein for use in the treatment of blood disorders; cDNA derived from mouse yolk sacs |
| 04/19/2007 | US20070087378 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 04/19/2007 | US20070087377 Methods and compositions for reverse translation |
| 04/19/2007 | US20070087376 Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases |
| 04/19/2007 | US20070087375 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710 |
| 04/19/2007 | US20070087372 Isolated ductal fluid sample |
| 04/19/2007 | US20070087371 Zinc finger domains and methods of identifying same |
| 04/19/2007 | US20070087370 Microarray probe Tm matching by selective destabilization |
| 04/19/2007 | US20070087369 Method for the Isolation of RNA from Biological Sources |
| 04/19/2007 | US20070087368 Method, System and Computer Software Providing a Genomic Web Portal for Functional Analysis of Alternative Splice Variants |
| 04/19/2007 | US20070087367 Method and apparatus for combinatorial chemistry |
| 04/19/2007 | US20070087366 Functional mutant loxP sequences and uses thereof |
| 04/19/2007 | US20070087365 Methylation markers for diagnosis and treatment of ovarian cancer |
| 04/19/2007 | US20070087364 In vitro erythroid micronucleus assay for genotoxicity |
| 04/19/2007 | US20070087363 Therapeutic methods, compounds and compositions |
| 04/19/2007 | US20070087362 Plurality of beads immobilized in a semi-solid medium to form an array; miniaturized, high density, clonal bead-based arrays; polymerase colony (polony) technology; hybridization, replication, genetic engineering |
| 04/19/2007 | US20070087361 Determining which allele is present in a sample tot reduce non-specific hybridization or reduce the impact of non-specific hybridization on the assay by using oligonucleotides having at least on non-standard base (iscytosine and isoguanine); kits |
| 04/19/2007 | US20070087360 Methods and compositions for detecting nucleotides |
| 04/19/2007 | US20070087359 predicting the likelihood that a feline of the breed Maine Coon cat will develop hypertrophic cardiomyopathy; providing a polynucleotide probe capable of hybridizing under stringent conditions to a region within the polynucleotide that encodes MYBPC |
| 04/19/2007 | US20070087358 Methods for diagnosing cancer based on DNA methylation status in NBL2 |
| 04/19/2007 | US20070087357 Lateral flow device with onboard reagents |
| 04/19/2007 | US20070087356 In situ assembling of protein microarrays |
| 04/19/2007 | US20070087355 Comparative genomic hybridization assays and compositions for practicing the same |
| 04/19/2007 | US20070087354 Lentiviral vector-based vaccine |
| 04/19/2007 | US20070087353 Microarray biochemical reaction device |
| 04/19/2007 | US20070087352 Inhibitors for androgen antagonist refractory prostate cancer |
| 04/19/2007 | US20070087351 Orotate transporter encoding maker genes |
| 04/19/2007 | US20070087350 Use of a mutation in the braf gene for the determination of the malignancy of melanoma cells |
| 04/19/2007 | US20070087349 Highly parallel template-based dna synthesizer |
| 04/19/2007 | US20070087348 System and method for carrying out multiple binding reactions in an array format |
| 04/19/2007 | US20070087347 Dose-dependent promoter originating in humans |
| 04/19/2007 | US20070087346 Orthogonal gene switches |
| 04/19/2007 | US20070087345 Assays for the direct measurement of gene dosage |
| 04/19/2007 | US20070087344 Methods for characterizing signaling pathways and compounds that interact therewith |
| 04/19/2007 | US20070087343 Method of detecting gene expression and kit and apparatus to be used therein |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070087341 Compositions for use in identification of influenza viruses |
| 04/19/2007 | US20070087340 Compositions for use in identification of influenza viruses |
| 04/19/2007 | US20070087339 Compositions for use in identification of influenza viruses |
| 04/19/2007 | US20070087338 Compositions for use in identification of influenza viruses |
| 04/19/2007 | US20070087337 Compositions for use in identification of influenza viruses |
| 04/19/2007 | US20070087336 Compositions for use in identification of influenza viruses |
| 04/19/2007 | US20070087335 Interference RNA for use in treatment and prevention of human immunodeficiency viral infection |
| 04/19/2007 | US20070087334 PKR activation via hybridization chain reaction |